Techtran Polylenses Ltd has informed BSE that the Shareholders at the Count Convened Extra Ordinary General Meeting of the Company held on November 12, 2011, have approved the Scheme of Amalgamation of Hemarus Therapeutics Ltd. with Techtran Polylenses Ltd.